Inhibition of HDAC6 using TubA improves skeletal muscle disorders in Duchenne Muscular Dystrophy (DMD) by modulating TGF-β signaling (Osseni et al., 2022). This evidence concerns the gene HDAC6 and Duchenne muscular dystrophy.